IL13 and myeloid sarcoma: In particular, a recent study has shown elevated levels of proinflammatory molecules (IL-6 and leptin) and reduced levels of the anti-inflammatory cytokine IL-13 in the cerebrospinal fluid (CSF) of obese MS patients, and patients with higher BMI (BMI > 30 kg/m2) also had significantly higher EDSS values (30).